Table 2.
Clinical Condition/Number of Patients (n) | CXCR5+CD8+ T cell phenotype | CXCR5+CD8+ T cell Clinical Correlation | Reference | |
---|---|---|---|---|
Anti-viral | HIV (n=36) |
IL-2+IFN-γ+IL-17+ | High circulating CXCR5+CD8+ T cell quantity correlates with HIV neutralization by plasma from HIV-infected children | (64) |
HIV (n=115) |
CCR7−/loCD62LhiIL-21hi TCF1hiBCL6hiBLIMP1− | High circulating CXCR5+CD8+ T cell quantity correlates with reduced HIV viral load | (63) | |
HIV (n=101) |
PD-1+ | High circulating HIV-specific CXCR5+CD8+ T cell quantity correlates with reduced HIV viral load | (8) | |
HIV (n=14) |
PD-1+CD44+KLRG1+ IFN-γ+CD107a+ | High circulating HIV-specific CXCR5+CD8+ T cell quantity correlates with reduced HIV viral load | (18) | |
Dengue Virus 2 (n=57) |
PD-1+ | High circulating anti-viral CXCR5+CD8+ T cell quantity correlates with reduced viral load and protection from associated kidney injury | (66) | |
Bacterial Infection | Bacterial Pneumonia (n=65) |
PD-1+CD103lo | High circulating CXCR5+CD8+ T cell quantity correlates with exacerbation of pneumonia severity | (67) |
Anti-tumor | Colorectal cancer (n=44) |
PD1hiTim3hiLAG3hi IFN-γhiTNF-αhiIL-2hi PRF1hiGZMBhi | High CXCR5+CD8+ T cell quantity in tumors or tumor draining lymph nodes correlates with increased cancer-free survival times | (22) |
HCC (n=40) |
PD-1hiICOShi IL-21hi | High tumor-infiltrating CXCR5+CD8+ T cell quantity negatively correlates with microvascular invasion, TNM staging and early recurrence | (23) | |
Pancreatic cancer (n=12) |
PD-1+TIM-3+ | High tumor-infiltrating and circulating CXCR5+CD8+ T cell quantity correlates with disease-free survival after tumor resection | (68) | |
Bladder cancer (n=11, fresh tissue for flow cytometry; n=249 bioinformatics gene signature) |
PD-1+CTLA-4+ CD62L+LAG3+ IFN-γ+GZMB+ TNF-α+CD107a+ | High tumor-infiltrating CXCR5+CD8+ T cell quantity correlates with lower tumor stage and prolonged overall survival and cancer-free survival | (69) | |
Follicular (Germinal Center B cell) lymphoma (n=187, bioinformatics gene expression) |
PD-1+IFN-γ+TNF-α+ | High tumor expression of CXCR5+CD8+ T cell signature genes correlates with prolonged survival | (70) | |
Autoimmunity | SLE (n=79) |
CD158e+ (Inhibitory, Killer cell Ig-like receptor, KIR+) | Reduced quantity of circulating CD158e+CD8+ T cells in SLE patients compared to healthy controls; KIR+CD8+ T cells potential human counterpart to murine Ly49+ Qa-1-restricted CD122hiCD8+ T cell related to protection from autoimmunity | (59) |
Transplantation | Kidney Transplant (n=95) |
CD44+CD62L−IFN-γ+ | High circulating CXCR5+CD8+ T cell quantity correlates with lower incidence of de novo donor specific antibody production and improved clinical outcomes at 1 year post transplant | (53) |